首页 | 本学科首页   官方微博 | 高级检索  
     

多西紫杉醇联合顺铂及5-氟脲嘧啶治疗晚期胃癌的疗效观察
引用本文:孙瑞. 多西紫杉醇联合顺铂及5-氟脲嘧啶治疗晚期胃癌的疗效观察[J]. 国际医药卫生导报, 2012, 18(22): 3293-3295
作者姓名:孙瑞
作者单位:730050,兰州市第一人民医院肿瘤科
摘    要:目的探讨DCF方案治疗晚期胃癌的临床疗效。方法将58例晚期胃癌患者分成观察组和对照组,观察组给予多西紫杉醇联合顺铂及5-氟脲嘧啶治疗方案,对照组给予顺铂治疗,观察两组患者近期疗效及毒副反应情况。结果观察组的总有效率明显高于对照组的(P〈0.05)观察组白细胞减少及腹泻的发生率高于对照组的(P〈0.05)。结论多西紫杉醇联合顺铂、5-氟脲嘧啶治疗晚期胃癌疗效显著。

关 键 词:晚期胃癌  DCF方案  临床疗效

Efficacy observation on DCF scheme in the treatment of advanced gastric cancer
SUN Rui. Efficacy observation on DCF scheme in the treatment of advanced gastric cancer[J]. International Medicine & Health Guidance News, 2012, 18(22): 3293-3295
Authors:SUN Rui
Affiliation:SUN Rui.( Oneology Department, The First People's Hospital of Lanzhou City, Lanzhou 730050, China)
Abstract:Objective To investigate the clinical efficacy of Docetaxel combined with cisplatin and 5-Fluorouraeil (DCF) scheme in the treatment of advanced gastric cancer. Methods 58 eases of advanced gastric cancer were divided into the observation group and the control group. The observation group was treated with DCF Scheme, while the control group treated with eisplatin. The recent efficacy, toxic and adverse effects of both groups were observed. Results The ORR of the observation group was significantly higher than that of the control group (P〈 0.05). As for the observation group, the incidence of leucopenia and diarrhea was higher than that of the control group (P〈 0.05). Conclusion DCF Scheme is effective in treatment of advanced gastric cancer.
Keywords:Advanced gastric cancer  DCF scheme  Clinical efficacy
本文献已被 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号